非小细胞肺癌18F-FDG摄取与EGFR突变的关系
【目的】 探讨非小细胞肺癌原发病灶18F氟代脱氧葡萄糖(18F-FDG)摄取与表皮生长因子受体突变的相互关系,及应用最大标准化摄取值预测EGFR突变以期指导临床酪氨酸激酶抑制剂的应用【方法】从2006年11月到2010年9月,收集66例在抗肿瘤治疗之前行EGFR突变检测及PET/CT扫描的NSCLC患者,用SUVmax描述原发病灶的18F-FDG摄取情况,采用荧光定量PCR法检测患者EGFR的突变情况,分析FDG摄取与EGFR突变的关系【结果】 本组病例中EGFR的19号及21号外显子的突变率为33%,突变型患者原发灶的SUVmax低于野生型患者(10 ± 5,14 ± 6,P = 0.006...
Saved in:
Format: | Article |
---|---|
Language: | zho |
Published: |
Editorial Office of Journal of Sun Yat-sen University
2011-01-01
|
Series: | Zhongshan Daxue xuebao. Yixue kexue ban |
Subjects: | |
Online Access: | http://xuebaoyx.sysu.edu.cn/zh/article/43577521/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
18 F-FDG PET/CT体积代谢参数在局限期小细胞肺癌预后的预测价值
by: 林晓平, et al.
Published: (2017-01-01) -
PET CT Imaging with FDG in the Therapeutical Management of Locally Advanced Cervical Cancer Diagnosed in a 43-Year-Old Patient: Case Report and Review of the Literature
by: Ottó Molnar, et al.
Published: (2025-01-01) -
泰素蒂联合顺铂治疗晚期非小细胞肺癌
Published: (2008-01-01) -
Predictive Value of Initial 18F-FDG PET/CT for Identifying EGFR and KRAS Mutations in Patients with Non-small-cell Lung Cancer
by: Ozge Vural Topuz, et al.
Published: (2024-11-01) -
盐酸厄洛替尼治疗晚期非小细胞肺癌不良反应的观察
Published: (2008-01-01)